EarliTec Diagnostics vs Immunarray
EarliTec Diagnostics vs Immunarray, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EarliTec Diagnostics is on 52/100 and Immunarray on 39/100.
Where each one leads
EarliTec Diagnostics
- our overall score: 52/100 against 39/100
- agent readiness: 47/100 against 28/100
- domain rating: 40/100 against 18/100
- funding raised: $41.0M against $10.0M
Immunarray
Leads on none of the measures we hold for both companies.
At a glance
| Measure | EarliTec Diagnostics | Immunarray |
|---|---|---|
| What it is | EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children. | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. |
| Category | Healthcare, Autism, Diagnostics, HealthTech | Healthcare, Blood, Diagnostics, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2019 | 2006 |
| Headquarters | Atlanta, United States | Richmond, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | EarliTec Diagnostics | Immunarray |
|---|---|---|
| Employees | 38 | Not published |
| Headcount growthLast 12 months | +13.2% | Not published |
| Total funding | $41.0M | $10.0M |
| Latest round | Series B | Series A |
| LinkedIn followers | 2,037 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EarliTec Diagnostics | Immunarray |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 39/100 |
| Traction | 54/100 | 35/100 |
| Team | 30/100 | 30/100 |
| Community | Not published | 13/100 |
| Search visibility | 33/100 | 5/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (28/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 18/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EarliTec Diagnostics | Immunarray |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
EarliTec Diagnostics vs Immunarray: common questions
Which is better, EarliTec Diagnostics or Immunarray?
On our 0-100 score EarliTec Diagnostics rates higher (52/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EarliTec Diagnostics and Immunarray compare on the numbers?
EarliTec Diagnostics leads on our overall score (52/100 against 39/100), agent readiness (47/100 against 28/100), domain rating (40/100 against 18/100), funding raised ($41.0M against $10.0M).
Read the full EarliTec Diagnostics review and pricing or the Immunarray review and pricing. You can also browse other EarliTec Diagnostics alternatives we track.